Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
Food and Drug Administration (FDA) approves Enjaymo (sutimlimab-jome)
Article: CAD Foundation Strives to Increase Knowledge of this disease.
Yoga and Holistic Management with Emily Taylor.
CAD Foundation Summit Series - March 23/2021
February 23, 2021 CAD/COVID & Dr. Furman's Webinar January 19, 2021
International Society for Pharmacoeconomics and Outcomes Research
Medical Advisors who have endorsed CADF
Feb 19, 2021
News Release, December, 07 2020
This is not a roadblock; it's only a detour.
Survey on the experience of patients living with cold agglutinin disease
My Dad's diagnosis of CAD. Part 2: Slowing Down
Understanding through experience, My Dad’s diagnosis of CAD Part 1.
FDA grants priority review of Sutimlimab. Potenial first approved treatment.
In support of rare disease patients that are impacted.
Welcome to CADdy News Our 3nd edition newsletter
Welcome to CADdy News Our 2nd edition newsletter
Welcome to CADdy News Our 1st edition newsletter
Copyright © 2022 Cold Agglutinin Disease Foundation - All Rights Reserved.
Contact Us: info@cadfadvocacy.org
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.